Liontrust Investment Partners LLP Has $127.45 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Liontrust Investment Partners LLP reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 234,532 shares of the medical equipment provider’s stock after selling 36,584 shares during the period. Intuitive Surgical accounts for approximately 1.8% of Liontrust Investment Partners LLP’s investment portfolio, making the stock its 14th biggest position. Liontrust Investment Partners LLP owned approximately 0.07% of Intuitive Surgical worth $127,447,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of ISRG. Tobam boosted its holdings in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new stake in Intuitive Surgical during the second quarter worth approximately $27,000. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. 1248 Management LLC acquired a new position in shares of Intuitive Surgical in the first quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical during the second quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Piper Sandler boosted their price target on Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Robert W. Baird set a $655.00 price target on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Argus raised their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $608.79.

Intuitive Surgical Stock Down 0.9%

ISRG stock opened at $542.32 on Friday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business has a 50-day simple moving average of $529.62 and a 200 day simple moving average of $505.69. The company has a market cap of $194.41 billion, a PE ratio of 71.74, a price-to-earnings-growth ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period last year, the firm earned $1.84 EPS. The business’s quarterly revenue was up 22.9% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares in the company, valued at $3,310,850. The trade was a 37.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 7,562 shares of the firm’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 109,043 shares of company stock valued at $60,816,225 over the last three months. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.